Clinical Trials in Los Angeles

Showing 8961-8980 of 16,901 trials

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

NCT03532035

This is a randomized, controlled, open-label, multicenter study to evaluate the safety, tolerability, pharmacokinetic (PK), and adenovirus (AdV) antiviral activity of multiple ascending doses of IV brincidofovir (BCV). Approximately 30 eligible subjects will be sequentially enrolled into 1 of 3 planned cohorts. Within each cohort, subjects will be randomized in a 4:1 ratio to receive IV BCV dosed twice weekly (BIW) (on Days 1, 4, 8, and 11) or to receive investigator-assigned standard of care (SoC).

Adenovirus

Jazz PharmaceuticalsStarted Dec 2018

Los Angeles, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

NCT03028363

The objectives of this study are to assess the safety and efficacy of Olumacostat Glasaretil Gel compared to vehicle in patients with acne vulgaris

Acne Vulgaris

Dermira, Inc.759 participantsStarted Dec 2016

Phoenix, Arizona, United States • Anaheim, California, United States • Los Angeles, California, United States +46 more locations

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Find Trials by Condition in Los Angeles

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

Study of Cryoablation for Metastatic Lung Tumors

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Phase 2/3 Study of IGSC, 20% in PIDD

A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Scoring System for Inhalation Injury

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia